References
- Booman G A, Eustis S L. Proliferative lesions of the exocrine pancreas in male F344/N rats. Environ Health Perspect 1984; 56: 213–7
- Eustis S L, Booman G A. Proliferative lesions of exocrine pancreas: relationship to corn oil gavage in the National Toxicology Program. J Natl Cancer Inst 1985; 75: 1067–73
- Haseman J K, Huff J E, Rao G N, et al. Neoplasms observed in treated and corn oil gavage control groups of F344/N rats and B6C3F1 mice. J Natl Cancer Inst 1985; 75: 975–83
- Sparks R E. Microencapsulation. Kirk-Othmer encyclopedia of chemical technology, 3rd edition, H F Mark, D F Othmer, C G Overberger, G T Seaburg. John Wiley & Sons, New York 1981; Vol. 15: 470–93
- Melnick R L, Jameson C W, Goehl T J, et al. Application of microencapsulation for toxicology studies. I. Principles and stabilization of trichloroethylene in gelatin-sorbitol microcapsules. Fundam Appl Toxicol 1987; 8: 425–31
- Melnick R L, Jameson C W, Goehl T J, et al. Application of microencapsulation for toxicology studies. II. Toxicity of microencapsulated trichloroethylene in Fisher 344 rats. Fundam Appl Toxicol 1987; 8: 432–42
- Bender M L, Komiyama M. Cyclodextrin chemistry. Berlin: Springer-Verlag 1978; 4–5
- Szejtli J. Cyclodextrins and their inclusion complexes. Budapest: Akademiai Kiado. 1982
- Pitha J, Szente L, Szejtli J. Molecular encapsulation of drugs by cyclodextrins and congeners. Controlled drug delivery, S D Bruck. CRC Press, Boca Raton, FL 1983; 125–48
- Frijlink H W, Visser J, Hefting N R, et al. The pharmacokinetics of β-cyclodextrin and hydroxypropylβ-cyclodextrin in the rat. Pharm Res 1990; 7: 1248–52
- Andersen G H, Robbins F M, Domingues F J, et al. The utilization of Schardinger dextrins by the rat. Toxicol Appl Pharmacol 1963; 5: 257–66
- Szejtli J, Gerloczy A, Fonagy A. Intestinal absorption of carbon-14-labelled β-cyclodextrin in rats. Arzneimittelforschung 1908; 30: 808–10
- Antenucci R N, Palmer J K. Enzymatic degradation of α- and β-cyclodextrins by Bacteroides of the human colon. J Agric Food Chem 1984; 32: 1316–21
- Makita T, Ojima N, Hashimoto Y, et al. Chronic oral toxicity study of β-cyclodextrin in rats. Oyo Yukuri 1975; 10: 449–58
- Szejtli J, Sebestyen G. Resorption. metabolism and toxicity studies on the peroral application of P-cyclodextrin. Starch/Staerke 1979; 31: 385–9
- Frijlink H W, Eissens A C, Hefting N R, et al. The effect of parenterally administered cyclodextrins on cholesterol levels in the rat. Pharm Res 1991; 8: 9–16
- Frank D W, Gray J E, Weaver R N. Cyclodextrin nephrosis in the rat. Am J Pathol 1976; 83: 367–82
- Serfozo J, Szabo P, Ferenczy T, et al. Renal effects of parenterally administered methylated cyclodextrins in rabbit. Proceedings of the First International Symposium on Cyclodextrins, J Szejtli. Doordrecht: Reidel Publ. Co., and Budapest: Akaderniai Kiado, 1983; 123
- Hara K, Hashimoto H. Application of cyclodextrin. J Jpn Soc Starch Sci 1986; 33: 152–61
- Szejtli J. The cyclodextrins and their applications in biotechnology. Carbohydrate Polym 1990; 12: 375–92
- Koizumi K, Kubota Y, Tanimoto T, et al. Determination of cyclic glucans by anion-exchange chromatography with pulsed amperometeric detection. J Chromatogr 1988; 454: 303–10
- Aboutaleb A E, Rahman A A, Ismail S. Studies of cyclodextrin inclusion complexes. Drug Der Indust Pharm 1986; 12: 2259–79
- Yuan J, Jameson C W, Goehl T J, et al. Application of molecular encapsulation fortoxicology studies: toxicokinetics of p-Chloro-α,α,α-trifluorotoluene in α-cyclodextrin or corn oil vehicles in male F344 rats. Toxicol Appl Pharmacol 1991; 111